Sysmex SSMXF Stock
Sysmex Price Chart
Sysmex SSMXF Financial and Trading Overview
Sysmex stock price | 19.34 USD |
Previous Close | 68.22 USD |
Open | 68.22 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 68.22 - 68.22 USD |
52 Week Range | 51.45 - 69.9 USD |
Volume | 46 USD |
Avg. Volume | 103 USD |
Market Cap | 14.9B USD |
Beta (5Y Monthly) | 0.619157 |
PE Ratio (TTM) | 42.64052 |
EPS (TTM) | 0.63 USD |
Forward Dividend & Yield | 0.63 (0.91%) |
Ex-Dividend Date | September 28, 2023 |
1y Target Est | N/A |
SSMXF Valuation Measures
Enterprise Value | -32778192896 USD |
Trailing P/E | 42.64052 |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.03629959 |
Price/Book (mrq) | 0.03682512 |
Enterprise Value/Revenue | -0.08 |
Enterprise Value/EBITDA | -0.304 |
Trading Information
Sysmex Stock Price History
Beta (5Y Monthly) | 0.619157 |
52-Week Change | 7.29% |
S&P500 52-Week Change | 20.43% |
52 Week High | 69.9 USD |
52 Week Low | 51.45 USD |
50-Day Moving Average | 66.48 USD |
200-Day Moving Average | 62.16 USD |
SSMXF Share Statistics
Avg. Volume (3 month) | 103 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 209.24M |
Float | 149.97M |
Short Ratio | N/A |
% Held by Insiders | 26.79% |
% Held by Institutions | 30.93% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 80 |
Trailing Annual Dividend Yield | 117.25% |
5 Year Average Dividend Yield | 74.00% |
Payout Ratio | 0.3539 |
Last Split Factor | 2:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2023 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | March 31, 2024 |
Profitability
Profit Margin | 11.15% |
Operating Margin (ttm) | 18.52% |
Gross Margin | 52.63% |
EBITDA Margin | 26.27% |
Management Effectiveness
Return on Assets (ttm) | 9.36% |
Return on Equity (ttm) | 12.40% |
Income Statement
Revenue (ttm) | 410.5B USD |
Revenue Per Share (ttm) | 1961.99 USD |
Quarterly Revenue Growth (yoy) | 6.60% |
Gross Profit (ttm) | N/A |
EBITDA | 107.86B USD |
Net Income Avi to Common (ttm) | 45.78B USD |
Diluted EPS (ttm) | 1.6 |
Quarterly Earnings Growth (yoy) | -5.29% |
Balance Sheet
Total Cash (mrq) | 70.33B USD |
Total Cash Per Share (mrq) | 336.14 USD |
Total Debt (mrq) | 22.59B USD |
Total Debt/Equity (mrq) | 5.82 USD |
Current Ratio (mrq) | 2.66 |
Book Value Per Share (mrq) | 1852.671 |
Cash Flow Statement
Operating Cash Flow (ttm) | 68.84B USD |
Levered Free Cash Flow (ttm) | 18.85B USD |
Profile of Sysmex
Country | United States |
State | N/A |
City | Kobe |
Address | 1-5-1 Wakinohama-kaigandori |
ZIP | 651-0073 |
Phone | 81 78 265 0500 |
Website | https://www.sysmex.co.jp |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | N/A |
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS. In addition, it offers cancer lymph node metastasis testing systems to detect information to help in diagnosing lymph node metastasis; and lab assay services. Further, the company is involved in the development and sale of software for diagnostic information systems; provision of facility management, office, welfare, and genetic analysis services; development, operation, and maintenance of IT solutions, platforms, and applications related to digital medicine; marketing, development, design, manufacture, sale, and after-sales service related to medical robots; and distribution and after sales support of medical devices and reagents for biotechnology, medical technology, and molecular cell analysis. Additionally, it researches, develops, manufactures, and sells regenerative medicine products; develops, manufactures, and sells biodevices; develops, maintains, and sells computer software; and offers blood DNA testing service. The company serves national and other public hospitals, private hospitals, universities, research institutes, other medical institutions, etc. It also exports its products to approximately 190 countries. The company was formerly known as TOA Medical Electronics Co., Ltd. and changed its name to Sysmex Corporation in October 1998. Sysmex Corporation was founded in 1968 and is headquartered in Kobe, Japan.
Q&A For Sysmex Stock
What is a current SSMXF stock price?
Sysmex SSMXF stock price today per share is 19.34 USD.
How to purchase Sysmex stock?
You can buy SSMXF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sysmex?
The stock symbol or ticker of Sysmex is SSMXF.
Which industry does the Sysmex company belong to?
The Sysmex industry is Medical Instruments & Supplies.
How many shares does Sysmex have in circulation?
The max supply of Sysmex shares is 623.6M.
What is Sysmex Price to Earnings Ratio (PE Ratio)?
Sysmex PE Ratio is 30.69841400 now.
What was Sysmex earnings per share over the trailing 12 months (TTM)?
Sysmex EPS is 0.63 USD over the trailing 12 months.
Which sector does the Sysmex company belong to?
The Sysmex sector is Healthcare.